# Caffeine Mouth Rinse on Salivary Immunoglobulin A, Lactoferrin and A-Amylase Levels

> **NCT06704711** · NA · NOT_YET_RECRUITING · sponsor: **University of Gaziantep** · enrollment: 30 (estimated)

## Conditions studied

- Exercise Response

## Interventions

- **DIETARY_SUPPLEMENT:** Caffeine 300 MG
- **COMBINATION_PRODUCT:** Exercise
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06704711
- **Lead sponsor:** University of Gaziantep
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2024-12-16
- **Final completion:** 2024-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06704711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06704711, "Caffeine Mouth Rinse on Salivary Immunoglobulin A, Lactoferrin and A-Amylase Levels". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06704711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*